Literature DB >> 6392471

Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies.

A Donohue-Rolfe, G T Keusch, C Edson, D Thorley-Lawson, M Jacewicz.   

Abstract

A simple purification scheme for shigella cytotoxin was devised, resulting in high yields (approximately 50%) and a 1,300-fold increase in specific activity compared with the initial crude bacterial cell lysate. The purified toxin was enterotoxic in ligated rabbit ileal loops and neurotoxic when injected into the peritoneal cavity of mice. Measurement of specific activity of cytotoxin and enterotoxin demonstrated that these two toxicities copurify during the fractionation procedure. On sodium dodecyl sulfate gel electrophoresis, the toxin migrated as two polypeptide subunits, an A subunit of 32,000 mol wt and a B subunit of 6,500 mol wt. Chemical cross-linking experiments demonstrate that the toxin is a complex consisting of one A and five B subunits with a molecular weight of 64,000. Polyclonal rabbit anti-toxin and anti-subunit B antisera were produced as well as subunit-specific mouse monoclonal antibodies. All antibodies preincubated with toxin neutralized cytotoxic effects in HeLa cell monolayers. In contrast, only A subunit-specific antibodies were able to neutralize toxin prebound to the HeLa cell surface. Antibody to the B subunit also inhibited binding of 125I-labeled toxin to these cells by 94% or more. These data demonstrate that the B subunit is involved in shigella toxin binding to the cell surface.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6392471      PMCID: PMC2187538          DOI: 10.1084/jem.160.6.1767

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  Restriction in vivo. III. General effects of glucosylation and restriction on phage T4 gene expression and replication.

Authors:  K Dharmalingam; E B Goldberg
Journal:  Virology       Date:  1979-07-30       Impact factor: 3.616

3.  The pathogenesis of shigella diarrhea. II. Enterotoxin-induced acute enteritis in the rabbit ileum.

Authors:  G T Keusch; G F Grady; A Takeuchi; H Sprinz
Journal:  J Infect Dis       Date:  1972-07       Impact factor: 5.226

Review 4.  Shigella toxin(s): description and role in diarrhea and dysentery.

Authors:  G T Keusch; A Donohue-Rolfe; M Jacewicz
Journal:  Pharmacol Ther       Date:  1981       Impact factor: 12.310

5.  The pathogenesis of Shigella diarrhea. VI. Toxin and antitoxin in Shigella flexneri and Shigella sonnei infections in humans.

Authors:  G T Keusch; M Jacewicz
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

6.  Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.

Authors:  M M Levine; R E Black; M L Clements; C R Young; C Lanata; S Sears; T Honda; R Finkelstein
Journal:  Dev Biol Stand       Date:  1983

7.  Isolation and characterization of Shigella shigae cytotoxin.

Authors:  S Olsnes; K Eiklid
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

8.  Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli.

Authors:  A D O'Brien; G D LaVeck
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

9.  Subunit structure of Shigella cytotoxin.

Authors:  S Olsnes; R Reisbig; K Eiklid
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

10.  The cytotoxic activity of Shigella toxin. Evidence for catalytic inactivation of the 60 S ribosomal subunit.

Authors:  R Reisbig; S Olsnes; K Eiklid
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

View more
  65 in total

1.  A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit.

Authors:  S B Calderwood; D W Acheson; M B Goldberg; S A Boyko; A Donohue-Rolfe
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

2.  Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron.

Authors:  K Ramotar; B Boyd; G Tyrrell; J Gariepy; C Lingwood; J Brunton
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

3.  Pathogenesis of Shigella diarrhea. XVI. Selective targetting of Shiga toxin to villus cells of rabbit jejunum explains the effect of the toxin on intestinal electrolyte transport.

Authors:  G Kandel; A Donohue-Rolfe; M Donowitz; G T Keusch
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

4.  Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin.

Authors:  B Boyd; S Richardson; J Gariepy
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

Review 5.  Current views on aetiology and management of haemolytic uraemic syndrome.

Authors:  M M Fitzpatrick; M J Dillon
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

6.  Latrunculin B facilitates Shiga toxin 1 transcellular transcytosis across T84 intestinal epithelial cells.

Authors:  Irina Maluykova; Oksana Gutsal; Marina Laiko; Anne Kane; Mark Donowitz; Olga Kovbasnjuk
Journal:  Biochim Biophys Acta       Date:  2008-02-20

7.  Expression and purification of Shiga-like toxin II B subunits.

Authors:  D W Acheson; S A De Breucker; M Jacewicz; L L Lincicome; A Donohue-Rolfe; A V Kane; G T Keusch
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

8.  Monoclonal antibodies specific for the bundle-forming pilus of enteropathogenic Escherichia coli.

Authors:  J A Girón; F Qadri; T Azim; K J Jarvis; J B Kaper; M J Albert
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

9.  Comparison of Shiga toxin production by hemolytic-uremic syndrome-associated and bovine-associated Shiga toxin-producing Escherichia coli isolates.

Authors:  Jenny M Ritchie; Patrick L Wagner; David W K Acheson; Matthew K Waldor
Journal:  Appl Environ Microbiol       Date:  2003-02       Impact factor: 4.792

10.  Production and characterization of protective human antibodies against Shiga toxin 1.

Authors:  Jean Mukherjee; Kerry Chios; Dianne Fishwild; Deborah Hudson; Susan O'Donnell; Stephen M Rich; Arthur Donohue-Rolfe; Saul Tzipori
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.